‘Compromise’ on TRIPS waiver is a sellout
Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools
The curious case of Covaxin royalties
ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth
Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …